clinic
cytolog
applic
ancillari
test
immunocytochemistri
often
limit
low
sampl
volum
poor
cell
represent
sampl
preserv
diagnostician
often
read
romanowskystain
cytolog
although
specif
techniqu
immunocytochemistri
often
essenti
definit
diagnosi
goal
present
studi
aim
investig
immunocytochemistri
previouslystain
cytolog
specimen
possibl
differ
pretreat
examin
determin
treatment
preserv
antigen
best
one
hundr
twentytwo
impress
smear
fineneedl
aspir
prepar
brain
lymph
node
process
evalu
microscop
impact
stain
cytolog
prepar
modifi
wright
stain
use
destain
method
perform
coverslip
decoverslip
process
subject
smear
microwav
treatment
mwt
examin
immunolabel
select
nuclear
cytoplasm
plasmalemm
antigen
well
intracellular
felin
coronaviru
fcov
biotinyl
secondari
antibodi
use
bound
primari
antibodi
visual
use
abc
amplif
kit
result
cellular
antigen
reliabl
detect
immunocytochemistri
smear
stain
romanski
stain
coverslip
earli
stain
stay
coverslip
immedi
immunolabel
stain
intens
reach
level
control
film
underw
mwt
citrat
buffer
contrast
fcov
antigen
detect
abolish
physicochem
interfer
poststain
immunocytochemistri
repres
practic
tool
addit
investig
prestain
cytolog
specimen
search
cellular
antigen
pair
untreat
sampl
kept
case
workup
requir
test
vulner
viral
antigen
coverslip
destain
felin
infecti
periton
microwav
neurocytolog
investig
cytolog
specimen
obtain
fineneedl
aspir
fna
least
invas
approach
obtain
diagnosi
diseas
cytomorpholog
howev
provid
limit
insight
biolog
neoplast
disord
etiolog
infecti
process
may
necessari
combin
cytomorpholog
specif
diseas
marker
elucid
underli
diseas
collect
predict
data
contrast
histolog
investig
allow
multipl
tissu
section
examin
individu
cell
repetit
impress
smear
fna
tissu
mean
reproduc
composit
cell
tissu
compon
addit
technolog
limit
type
distribut
lesion
pose
essenti
limit
holist
cytolog
character
thu
detect
compromis
lesion
poorli
exfoli
low
cellular
b
affect
tissu
difficult
access
eg
central
nervou
system
c
atyp
cell
pathogen
poorli
dens
scantli
distribut
cell
highli
vulner
shear
stress
detect
chang
sampl
low
cellular
multipl
investig
carri
slide
rather
singl
investig
multipl
slide
variabl
cell
number
simplest
secondari
procedur
use
convent
stain
highlight
microorgan
chemic
compound
matrix
compon
subcellular
structur
histochemistri
destain
procedur
advanc
panopt
stain
special
stain
mainli
focus
assess
microbi
fungal
organ
eg
ziehlneelsen
fitefaraco
gram
fontanamasson
mucin
polysaccharid
eg
alcian
blue
period
acidschiff
iron
pigment
melanin
eg
prussian
blue
reaction
nile
blue
fontanamasson
cellular
identif
rare
need
situat
ancillari
stain
often
conduct
spare
slide
infecti
diseas
tumor
cell
antigen
howev
could
requir
preselect
cytomorpholog
character
cell
stain
hold
true
particular
advanc
tumor
diagnos
immunocytochemistri
icc
romanskystain
prestain
slide
poststain
icc
psicc
could
help
identifi
histogenet
origin
tumor
cell
type
character
cell
identifi
convent
stain
obtain
prognost
predict
inform
infecti
diseas
psicc
promis
tool
intracellular
detect
viral
protein
one
common
situat
detect
felin
coronaviru
fcov
diagnosi
felin
infecti
periton
fip
presenc
intracellular
viral
antigen
macrophag
must
demonstr
approach
requir
preserv
target
antigen
host
cell
morpholog
histor
psicc
methodolog
tailor
individu
case
therefor
systemat
studi
reproduc
efficaci
reliabl
immunostain
rare
henc
present
studi
aim
fill
gap
establish
reproduc
guidelin
psicc
label
select
cellular
viral
antigen
tissu
imprint
fna
cytocentrifug
fluid
focu
specif
antigen
preserv
retriev
target
antigen
select
driven
daili
neurocytolog
specimen
caseload
variou
mammalian
speci
possibl
inflammatori
infecti
cn
diseas
studi
investig
abil
appli
icc
prestain
cytolog
specimen
b
whether
coverslip
could
use
preserv
antigen
c
whether
microwav
treatment
mwt
enhanc
immunodetect
prestain
smear
therefor
icc
stain
qualiti
evalu
smear
prestain
modifi
wright
stain
modw
destain
hydrochlor
acid
hcl
compar
unstain
sampl
without
coverslip
mwt
effect
evalu
set
cellular
antigen
distinct
subcellular
distribut
studi
intracellular
fcov
protein
studi
b
test
impact
individu
pretreat
immunostain
nuclear
cytoplasm
membran
antigen
therefor
systemat
evalu
employ
distinct
methodolog
trial
illustr
figur
tabl
seri
impress
smear
fna
prepar
taken
brain
lymph
node
cat
pig
postmortem
examin
hour
euthanasia
reason
unrel
studi
purpos
cn
cell
obtain
postcruci
gyru
brain
extens
craniectomi
encephalectomi
trim
describ
elsewher
lymphocyteenrich
sampl
collect
superfici
cervic
paraaort
lymph
node
via
fna
use
syring
prepar
airdri
immedi
plu
addit
effect
addit
coverslippingdecoverslip
cycl
sdscdc
slide
trial
investig
anoth
slide
trial
compar
cdctreat
slide
trial
seri
slide
subject
treatment
serv
gold
standard
trial
tabl
sampl
store
month
slide
except
trial
subject
laboratori
treatment
mention
preced
icc
coverslip
sampl
trial
immers
xylen
achiev
liquefact
mount
medium
coverslip
slip
thereaft
slide
put
grade
ethanol
seri
minut
immers
distil
water
prestain
decoverslip
slide
trial
left
uncov
modw
method
trial
immers
hcl
color
complet
fade
identifi
microscopi
freshli
destain
slide
trial
nonstain
decoverslip
slide
trial
immers
distil
water
icc
perform
figur
tabl
perform
icc
one
set
slide
trial
trial
n
trial
n
figur
tabl
subject
mwtbase
antigen
retriev
f
g
u
r
e
schemat
illustr
stain
trial
trial
slide
stain
coverslip
slide
use
cytomorpholog
evalu
trial
procedur
includ
stain
coverslip
microwav
treatment
slide
storag
directli
immunocytochemistri
specimen
decoverslip
destain
half
slide
microwavetr
trial
slide
stain
store
immunocytochemistri
time
slide
destain
half
microwav
treat
trial
slide
stain
coverslip
storag
directli
immunocytochemistri
decoverslip
destain
half
microwav
treat
trial
procedur
includ
coverslip
slide
immunocytochemistri
slide
decoverslip
half
microwav
treat
trial
pretreat
carri
specimen
store
frozen
half
slide
pretreat
microwav
immunocytochemistri
unstain
untreat
slide
serv
gold
standard
studi
procedur
slide
transfer
cuvett
contain
moll
citrat
buffer
solut
ph
base
immunohistochem
protocol
mwt
carri
w
follow
w
slide
left
citrat
buffer
minut
cool
room
temperatur
step
except
primari
antibodi
pab
incub
carri
room
temperatur
mwt
slide
kept
distil
water
destain
unstain
slide
without
mwt
tabl
upon
remov
nonimmun
serum
lymph
node
fna
incub
antibodi
detect
correspond
cell
antigen
marker
specif
neun
gfap
use
separ
brain
smear
tabl
run
contain
sitematch
slide
pab
replac
antibodi
diluent
serv
neg
control
altogeth
n
incub
carri
hour
repeat
wash
step
pb
slide
mount
biotinyl
goat
antirabbitmous
igg
antibodi
dako
glostrup
denmark
hour
bound
pab
subsequ
visual
use
abc
amplif
kit
vectastain
vector
laboratori
inc
burlingam
ca
usa
use
diaminobenzidin
tetrahydrochlorid
dab
chromagen
enzym
reaction
block
pb
rins
slide
counterstain
mayer
hematoxylin
applichem
gmbh
darmstadt
germani
underw
ascend
ethanol
seri
coverslip
describ
cell
yield
preserv
assess
bright
field
microscopi
two
differ
clinic
pathologist
separ
session
observ
blind
smear
origin
pretreat
type
pab
type
evalu
icc
outcom
icc
qualiti
determin
cell
type
specif
b
intens
cellular
stain
c
presenceabs
acellular
background
activ
nonspecif
stain
paramet
semiquantit
score
use
system
event
intraobserv
disagr
slide
review
b
l
e
differ
pretreat
appli
perform
immunocytochemistri
trial
trial
germani
mean
valu
newli
assign
statist
evalu
final
score
compar
differ
procedur
use
nonparametr
statist
algorithm
p
indic
statist
signific
studi
evalu
impact
pretreat
fcov
antigen
immunolabel
studi
b
conduct
pleural
n
abdomin
n
effus
fip
case
confirm
histopatholog
fcov
antigenposit
immunohistochemistri
effus
collect
use
convent
thoracentesi
abdominocentesi
procedur
harvest
fluid
mount
onto
uncoat
standard
slide
langenbrinck
emmendingen
germani
use
cytocentrifug
hettich
univers
adelsri
germani
accord
inhous
protocol
effus
centrifug
chamber
spun
minut
supernat
remov
coat
slide
centrifug
minut
slide
airdri
store
process
evalu
preserv
antigen
viral
antigen
sampl
underw
trial
without
mwt
describ
studi
icc
perform
use
mous
monoclon
antibodi
direct
coronaviru
nucleocapsid
clone
tabl
incub
subsequ
step
ident
appli
neun
label
see
use
abc
enhanc
dab
icc
signal
reevalu
observ
concern
cellular
subcellular
local
intens
specif
background
describ
evalu
cell
preserv
slide
microscop
assess
modwsstain
slide
reveal
repres
cell
yield
fewer
cell
suffer
crush
artifact
fewer
f
g
u
r
e
outcom
immunocytochem
stain
cellular
antigen
blue
arrow
specif
posit
stain
black
arrow
immunoneg
cell
counterstain
mayer
hematoxylin
immunocytochemistri
unstain
untreat
film
serv
gold
standard
illustr
optim
stain
result
signal
strongest
peripheri
lymphocyt
cytoplasm
close
membran
neun
immunoreact
restrict
neuron
nuclei
gfap
diffus
stain
soma
fragment
process
astrocyt
procedur
depict
trial
without
microwav
treatment
b
impact
xylenebas
coverslip
decoverslip
appear
neglig
henc
microwav
treatment
necessari
procedur
depict
trial
without
microwav
treatment
c
prestain
wright
stain
bleach
hydrogen
chlorid
abolish
specif
immunostain
marker
blue
arrow
slide
left
uncoverslip
procedur
depict
trial
without
microwav
treatment
coverslip
prestain
wright
stain
appear
superior
abl
preserv
antigen
specif
stain
intens
procedur
depict
trial
without
microwav
treatment
e
microwav
treatment
complet
rescu
compromis
effect
stainingdestain
coverslip
decoverslip
procedur
depict
trial
microwav
treatment
neun
neuron
nuclei
gfap
glial
fibrillari
acid
protein
cell
marker
wave
imag
depict
microwav
treatment
upsid
imag
depict
antibodi
treatment
coverslip
indic
coverslippingdecoverslip
techniqu
et
al
gfap
score
figur
tabl
gfap
background
brownish
cloudi
sometim
floccul
lowintens
stain
evid
specimen
tabl
howev
background
interfer
distinct
stain
astrocyt
somata
regard
subcellular
distribut
icc
plain
slide
signal
strongest
peripheri
lymphocyt
cytoplasm
close
membran
neun
immunoreact
restrict
neuron
nuclei
gfap
diffus
stain
soma
fragment
process
astrocyt
even
coverslip
decoverslip
cdc
trial
icc
permit
identif
three
cell
type
figur
howev
stain
intens
cell
specif
neun
specimen
significantli
lower
observ
trial
p
gfap
background
stain
stronger
p
tabl
sd
trial
interfer
immunolabel
icc
perform
within
day
romanowski
stain
howev
delay
week
abolish
immunolabel
significantli
figur
henc
detect
marker
sever
compromis
cell
specif
p
intens
tabl
weak
cellular
stain
seen
isol
lymphocyt
astrocyt
major
cell
specimen
remain
immunoneg
earli
coverslip
modwsstain
specimen
trial
rescu
antigen
three
antigen
compar
prestain
noncoverslip
slide
trial
intens
cell
specif
figur
tabl
specif
signal
obtain
slide
median
signal
intens
si
tabl
nonspecif
background
stain
restrict
mostli
gfap
slide
remain
distinct
cellular
chromagen
enrich
seen
figur
tabl
notabl
sdscdc
affect
subcellular
distribut
immunostain
signal
extend
throughout
lymphocyt
cytoplasm
rather
accentu
peripheri
gfap
stain
astrocyt
leak
nucleu
neun
stain
still
mainli
confin
neuron
nuclei
howev
signal
patchi
encompass
entir
nuclear
area
figur
posit
effect
mwt
restrict
coverslip
slide
omiss
coverslip
trial
fail
rescu
antigen
type
chemic
pretreat
trial
complet
abolish
immunostain
fcov
nucleocapsid
figur
b
tabl
therefor
contrast
immunodetect
cellular
antigen
coverslip
protect
viral
antigen
stain
slide
tabl
likewis
mwt
preclud
immunostain
plain
slide
trial
henc
fail
rescu
antigen
label
pretreat
slide
contamin
differ
yield
cell
composit
among
consecut
sampl
tradit
mwt
use
immunohistochemistri
formalinfix
tissu
antigen
recoveri
crosslink
aldehyd
bridg
similarli
mwt
proven
use
antigen
demask
cytolog
specimen
fixat
ethanol
formalin
cytolog
stain
howev
mwt
fail
recov
viral
antigen
detect
studi
instead
mwt
alon
effect
abolish
immunolabel
fcov
untreat
unstain
film
furthermor
possibl
reestablish
immunostain
anteced
cytolog
stain
coverslip
thu
fcov
epitop
appear
much
vulner
chang
induc
physicochem
factor
cellular
protein
investig
studi
whether
viral
antigen
preserv
achiev
prior
fixat
smear
describ
microbi
antigen
chlamydia
current
investig
studi
propos
fixat
formalin
ethanol
improv
icc
result
fcov
detect
airdri
prestain
film
grate
head
technician
neuropatholog
cytolog
lab
mr
karin
stingl
excel
technic
assist
author
indic
affili
financi
involv
organ
entiti
financi
interest
financi
competit
subject
matter
materi
discuss
articl
